Purpose: To develop a single validated model for survival in metastatic renal cell carcinoma
(mRCC) using a comprehensive international database. Experimental Design: A …

Background Current follow-up strategies for patients with renal cell carcinoma (RCC) after
curative surgery rely mainly on risk models and the treatment delivered, regardless of the …

Objectives To explore the real-world data regarding survival following metastasectomy (MS)
for renal cell carcinoma (RCC) in the postcytokine therapy era. Patients and Methods …

Background Recent publications have reported an association between increased renal
cancer-specific mortality (CSM) and reduced renal function “below safety limits,” and …

Patients with RCC may present with local or systemic symptoms, although most
presentations are incidental owing to the widespread use of abdominal imaging. Local signs …

From 1994 to 2003, the tumor registry at Baylor University Medical Center at Dallas recorded
700 patients with RCC (424 men and 276 women); most patients were diagnosed in the fifth …

OBJECTIVES: The European Association of Urology (EAU) Guideline Group for renal cell
carcinoma (RCC) prepared this guideline to help urologists assess the evidence-based …

BACKGROUND: Nephron-sparing surgery (NSS) can safely be performed with slightly
higher complication rates than radical nephrectomy (RN), but proof of oncologic …

Background Immuno-oncology (IO) agents and tyrosine kinase inhibitors (TKIs) have
revolutionized the treatment paradigm for metastatic renal cell carcinoma (mRCC). Data on …

Objectives Variability in survival after surgical treatment is observed in patients with renal
cell carcinoma (RCC), thereby affirming the heterogeneity of the disease. The aim of our …